{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:41:40Z","timestamp":1779277300356,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.molmed.2004.10.001","type":"journal-article","created":{"date-parts":[[2004,11,3]],"date-time":"2004-11-03T17:09:46Z","timestamp":1099501786000},"page":"591-598","source":"Crossref","is-referenced-by-count":11,"title":["Targeting promiscuous signaling pathways in cancer: another Notch in the bedpost"],"prefix":"10.1016","volume":"10","author":[{"given":"Levi J.","family":"Beverly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Capobianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2004.10.001_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2004.10.001_bib2","first-page":"1903","article-title":"Roscovitine induces cell death and morphological changes indicative of apoptosis in MDA-MB-231 breast cancer cells","volume":"59","author":"Mgbonyebi","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2004.10.001_bib3","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/15531","article-title":"Leukaemia disease genes: large-scale cloning and pathway predictions","volume":"23","author":"Li","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2004.10.001_bib4","first-page":"29","article-title":"Retroviral insertional mutagenesis as a strategy to identify cancer genes","volume":"1287","author":"Jonkers","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2004.10.001_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0065-230X(03)88304-5","article-title":"Retroviral insertional mutagenesis: tagging cancer pathways","volume":"88","author":"Mikkers","year":"2003","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.molmed.2004.10.001_bib6","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1128\/JVI.77.3.2056-2062.2003","article-title":"Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas","volume":"77","author":"Kim","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2004.10.001_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/ng950","article-title":"High-throughput retroviral tagging to identify components of specific signaling pathways in cancer","volume":"32","author":"Mikkers","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2004.10.001_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/22788","article-title":"Essential role for oncogenic Ras in tumour maintenance","volume":"400","author":"Chin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2004.10.001_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/71691","article-title":"Reversibility of acute B-cell leukaemia induced by BCR\u2013ABL1","volume":"24","author":"Huettner","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2004.10.001_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1097-2765(00)80367-6","article-title":"Reversible tumorigenesis by MYC in hematopoietic lineages","volume":"4","author":"Felsher","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2004.10.001_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/84691","article-title":"c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations","volume":"7","author":"D'Cruz","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2004.10.001_bib12","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1101\/gad.13.20.2658","article-title":"Disruption of the ARF\u2013Mdm2\u2013p53 tumor suppressor pathway in Myc-induced lymphomagenesis","volume":"13","author":"Eischen","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2004.10.001_bib13","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1128\/MCB.23.20.7256-7270.2003","article-title":"c-Myc augments \u03b3-irradiation-induced apoptosis by suppressing Bcl-XL","volume":"23","author":"Maclean","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2004.10.001_bib14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0092-8674(91)90111-B","article-title":"TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms","volume":"66","author":"Ellisen","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2004.10.001_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/dbio.2000.9960","article-title":"Notch signaling: from the outside in","volume":"228","author":"Mumm","year":"2000","journal-title":"Dev. Biol."},{"key":"10.1016\/j.molmed.2004.10.001_bib16","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/embo-reports\/kvf170","article-title":"Keeping a good pathway down: transcriptional repression of Notch pathway target genes by CSL proteins","volume":"3","author":"Lai","year":"2002","journal-title":"EMBO Rep."},{"key":"10.1016\/j.molmed.2004.10.001_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00062752-200107000-00010","article-title":"Notch signaling in leukemia","volume":"8","author":"Aster","year":"2001","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.molmed.2004.10.001_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0092-8674(94)90407-3","article-title":"The Ikaros gene is required for the development of all lymphoid lineages","volume":"79","author":"Georgopoulos","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2004.10.001_bib19","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1128\/MCB.14.11.7111","article-title":"The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene","volume":"14","author":"Hahm","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2004.10.001_bib20","doi-asserted-by":"crossref","first-page":"8292","DOI":"10.1128\/MCB.14.12.8292","article-title":"The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins","volume":"14","author":"Molnar","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2004.10.001_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1097-2765(03)00043-1","article-title":"Selective dimerization of a C2H2 zinc finger subfamily","volume":"11","author":"McCarty","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2004.10.001_bib22","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1002\/j.1460-2075.1996.tb00920.x","article-title":"Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development","volume":"15","author":"Sun","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2004.10.001_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0092-8674(95)90170-1","article-title":"A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma","volume":"83","author":"Winandy","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2004.10.001_bib24","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1200\/JCO.1999.17.12.3753","article-title":"Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia","volume":"17","author":"Sun","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molmed.2004.10.001_bib25","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1182\/blood.V95.8.2719","article-title":"The Ikaros gene, a central regulator of lymphoid differentiation, fuses to the BCL6 gene as a result of t(3;7)(q27;p12) translocation in a patient with diffuse large B-cell lymphoma","volume":"95","author":"Hosokawa","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2004.10.001_bib26","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1038\/sj.onc.1203293","article-title":"Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5\u2032-RACE and LA \u2013 PCR analyses of biopsy samples","volume":"18","author":"Yoshida","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2004.10.001_bib27","first-page":"3931","article-title":"Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia","volume":"59","author":"Nakayama","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2004.10.001_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1535-6108(03)00137-5","article-title":"Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in NotchIC-induced T cell leukemogenesis","volume":"3","author":"Beverly","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2004.10.001_bib29","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1101\/gad.816400","article-title":"Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding","volume":"14","author":"Cobb","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2004.10.001_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1074-7613(00)80034-5","article-title":"Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes","volume":"10","author":"Kim","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2004.10.001_bib31","doi-asserted-by":"crossref","first-page":"19594","DOI":"10.1074\/jbc.M000254200","article-title":"Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity","volume":"275","author":"Koipally","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2004.10.001_bib32","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1101\/gad.905601","article-title":"Down-regulation of TDT transcription in CD4+CD8+ thymocytes by Ikaros proteins in direct competition with an Ets activator","volume":"15","author":"Trinh","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2004.10.001_bib33","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1101\/gad.1040502","article-title":"A common mechanism for mitotic inactivation of C2H2 zinc finger DNA-binding domains","volume":"16","author":"Dovat","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2004.10.001_bib34","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1128\/MCB.24.7.2797-2807.2004","article-title":"Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition","volume":"24","author":"Gomez-del Arco","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2004.10.001_bib35","unstructured":"Lopez-Nieva, P. et al. (2004) Altered expression of Notch1, Notch2, c-Myc and Ikaros in \u03b3-radiation induced mouse thymic lymphomas. Carcinogenesis"},{"key":"10.1016\/j.molmed.2004.10.001_bib36","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-\u03baB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2004.10.001_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1034\/j.1600-065X.2003.00049.x","article-title":"Transducing signals from antigen receptors to nuclear factor \u03baB","volume":"193","author":"Ruland","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2004.10.001_bib38","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.1038\/sj.onc.1207230","article-title":"To be, or not to be: NF-\u03baB is the answer \u2013 role of Rel\/NF-\u03baB in the regulation of apoptosis","volume":"22","author":"Kucharczak","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2004.10.001_bib39","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1126\/science.278.5344.1812","article-title":"Requirement of NF-\u03baB activation to suppress p53-independent apoptosis induced by oncogenic Ras","volume":"278","author":"Mayo","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.molmed.2004.10.001_bib40","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.onc.1203392","article-title":"NF-\u03baB is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis","volume":"19","author":"Jo","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2004.10.001_bib41","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.12.7.968","article-title":"A requirement for NF-\u03baB activation in Bcr\u2013Abl-mediated transformation","volume":"12","author":"Reuther","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2004.10.001_bib42","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1128\/MCB.18.4.2077","article-title":"NF-\u03baB2 is a putative target gene of activated Notch-1 via RBP-J\u03ba","volume":"18","author":"Oswald","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2004.10.001_bib43","doi-asserted-by":"crossref","first-page":"24359","DOI":"10.1074\/jbc.M211051200","article-title":"Basal expression of I\u03baB\u03b1 is controlled by the mammalian transcriptional repressor RBP-J (CBF1) and its activator Notch1","volume":"278","author":"Oakley","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2004.10.001_bib44","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0960-9822(02)00743-1","article-title":"Notch activation of yan expression is antagonized by RTK\/pointed signaling in the Drosophila eye","volume":"12","author":"Rohrbaugh","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2004.10.001_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MCB.17.1.1","article-title":"The mammalian transcriptional repressor RBP (CBF1) regulates interleukin-6 gene expression","volume":"17","author":"Kannabiran","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2004.10.001_bib46","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1093\/nar\/27.13.2785","article-title":"Interaction of the nuclear protein CBF1 with the \u03baB site of the IL-6 gene promoter","volume":"27","author":"Palmieri","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2004.10.001_bib47","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/nar\/28.10.2091","article-title":"Functional interactions between an atypical NF-\u03baB site from the rat CYP2B1 promoter and the transcriptional repressor RBP-J\u03ba\/CBF1","volume":"28","author":"Lee","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2004.10.001_bib48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/306395a0","article-title":"A putative second cell-derived oncogene of the avian leukaemia retrovirus E26","volume":"306","author":"Leprince","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2004.10.001_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-1119(02)01156-3","article-title":"Molecular biology of the Ets family of transcription factors","volume":"303","author":"Oikawa","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.molmed.2004.10.001_bib50","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/35099076","article-title":"The ETS-domain transcription factor family","volume":"2","author":"Sharrocks","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2004.10.001_bib51","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1128\/MCB.16.5.2453","article-title":"Spi-1\/PU.1 transgenic mice develop multistep erythroleukemias","volume":"16","author":"Moreau-Gachelin","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2004.10.001_bib52","first-page":"149","article-title":"Spi-1\/PU.1: an oncogene of the Ets family","volume":"1198","author":"Moreau-Gachelin","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2004.10.001_bib53","first-page":"1511","article-title":"Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11","volume":"10","author":"Buijs","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2004.10.001_bib54","doi-asserted-by":"crossref","first-page":"9281","DOI":"10.1128\/MCB.20.24.9281-9293.2000","article-title":"The MN1\u2013TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity","volume":"20","author":"Buijs","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2004.10.001_bib55","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1128\/MCB.22.11.3927-3941.2002","article-title":"Characterization of a high-molecular-weight Notch complex in the nucleus of Notch(ic)-transformed RKE cells and in a human T-cell leukemia cell line","volume":"22","author":"Jeffries","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2004.10.001_bib56","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1128\/MCB.21.13.4337-4346.2001","article-title":"A human protein with sequence similarity to Drosophila mastermind coordinates the nuclear form of notch and a CSL protein to build a transcriptional activator complex on target promoters","volume":"21","author":"Kitagawa","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2004.10.001_bib57","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/82644","article-title":"MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors","volume":"26","author":"Wu","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2004.10.001_bib58","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/MCB.23.2.655-664.2003","article-title":"Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling","volume":"23","author":"Weng","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2004.10.001_bib59","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"issue":"Suppl. 3","key":"10.1016\/j.molmed.2004.10.001_bib60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0093-7754(01)90188-5","article-title":"Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials","volume":"28","author":"Slamon","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.molmed.2004.10.001_bib61","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1182\/blood.V93.11.3678","article-title":"Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate","volume":"93","author":"Sievers","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2004.10.001_bib62","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.2174\/1381612023393053","article-title":"BAY 43-9006: early clinical data in patients with advanced solid malignancies","volume":"8","author":"Hotte","year":"2002","journal-title":"Curr. Pharm. Des."},{"issue":"Suppl. 1","key":"10.1016\/j.molmed.2004.10.001_bib63","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1023\/A:1011167909059","article-title":"Phase I and II clinical trials of trastuzumab","volume":"12","author":"Baselga","year":"2001","journal-title":"Ann. Oncol"},{"key":"10.1016\/j.molmed.2004.10.001_bib64","first-page":"109","article-title":"Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia","volume":"16","author":"Rowley","year":"1973","journal-title":"Ann. Genet."},{"key":"10.1016\/j.molmed.2004.10.001_bib65","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell","year":"1960","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.molmed.2004.10.001_bib66","first-page":"1810","article-title":"Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group","volume":"91","author":"Gale","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2004.10.001_bib67","first-page":"1517","article-title":"An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology","volume":"94","author":"Silver","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2004.10.001_bib68","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1126\/science.289.5486.1938","article-title":"Structural mechanism for STI-571 inhibition of abelson tyrosine kinase","volume":"289","author":"Schindler","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.molmed.2004.10.001_bib69","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR\u2013ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2004.10.001_bib70","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR\u2013ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2004.10.001_bib71","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR\u2013ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.molmed.2004.10.001_bib72","first-page":"7149","article-title":"Activity of the BCR\u2013ABL kinase inhibitor PD180970 against clinically relevant BCR\u2013ABL isoforms that cause resistance to imatinib mesylate (Gleevec, STI571)","volume":"62","author":"La Rosee","year":"2002","journal-title":"Cancer Res."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149140400259X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149140400259X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T19:11:40Z","timestamp":1585941100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149140400259X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":72,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S147149140400259X"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2004.10.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}